Last updated: May 1, 2024
Sponsor: Oregon Health and Science University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Miscarriage
Treatment
Bilateral alternating stimulation
Clinical Study ID
NCT06353243
STUDY00022901
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- admitted to the NICU at the time of study
- greater than 34 weeks gestational age and less than 43 weeks gestational age
- within 4 weeks of admission to NICU at time of initial contact
- have parent or legal guardian willing and able to participate in the study
Exclusion
Exclusion Criteria:
- those who are less than 3 days postop from surgical procedures
- current use of psychotropic medications or medications that affect the central nervoussystem (CNS)
- CNS anomaly.
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Bilateral alternating stimulation
Phase:
Study Start date:
February 26, 2024
Estimated Completion Date:
August 31, 2024
Study Description
Connect with a study center
Oregon Health and Science University Neonatal Intensive Care Unit
Portland, Oregon 97219
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.